Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05324397 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)
A NA study of Chronic Rhinitis, sponsored by Neurent Medical.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 4
- Study locations
NCT05324397: Completed NA study of Chronic Rhinitis, sponsored by Neurent Medical.
NCT05324397 is a NA study of Chronic Rhinitis that has completed, run by Neurent Medical. The registered enrollment target is 36 participants, below the 91-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05324397, a NA study of Chronic Rhinitis, has completed, sponsored by Neurent Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 4
- Study locations
Study Summary
The CLARITY Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.
Primary Outcome
SAEs were defined per ICH-GCP (E6). This measure includes all SAEs assessed by the investigator as related to the device and/or procedure within 1 month post-procedure.
Conditions Studied
Interventions
- DEVICE NEUROMARK System
Study Locations (4)
Alabama
- Alabama Nasal and Sinus Center - Birmingham
Maryland
- Centers for Advanced ENT Care - Baltimore
Pennsylvania
- Specialty Physician Associates - Bethlehem
Washington
- ENT & Allergy Associcates - Puyallup
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2023-10-04 |
| Phase | NA |
What the finished NCT05324397 record still lists
NCT05324397 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 91-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Chronic Rhinitis appearing as the primary indexed condition, and to 1 intervention - of which NEUROMARK System is the first listed.
NCT05324397 reports a single indexed study location in Alabama, Maryland, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05324397 about?
NCT05324397 is a clinical study titled "Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)". The CLARITY Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.
What is the current status of trial NCT05324397?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2022-03-14. Estimated completion is 2023-10-04.
What conditions does trial NCT05324397 study?
This clinical trial studies the following conditions: Chronic Rhinitis.
What interventions are being tested in trial NCT05324397?
The interventions under investigation include: NEUROMARK System (DEVICE).
Who is sponsoring clinical trial NCT05324397?
This trial is sponsored by Neurent Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05324397 being conducted?
This trial has 4 study locations across Alabama, Maryland, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of RhinAer Stylus for Treating Chronic Rhinitis
ACTIVE NOT RECRUITING · NA
-
NEUROMARK Registry Study
ACTIVE NOT RECRUITING · NA
-
Multi-Treatment PNN Modulation for Chronic Rhinitis
COMPLETED · NA
-
ClariFix Rhinitis RCT
COMPLETED · NA
-
A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)
COMPLETED · NA
-
Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI